Table 2.
The prevalence of T2D-coexisting diseases in respondents with NI-T2D and non-diabetics classified by their amount (n)
| Number of coexisting diseases (n) | Hypertension n (%) | Hypercholesterolemia n (%) | Musculoskeletal disorders n (%) | Heart problems n (%) | Sleep problems n (%) | GI disorders n (%) | Kidney disease n (%) |
|---|---|---|---|---|---|---|---|
| NI-T2D | |||||||
| 1 (97) | 61 (62.9) | 24 (24.7) | 3 (3.1) | 2 (2.1) | 4 (4.1) | 3 (3.1) | 0 (0.0) |
| 2 (137) | 115 (83.9) | 106 (77.4) | 16 (11.7) | 18 (13.1) | 12 (8.8) | 7 (5.1) | 0 (0.0) |
| 3 (122) | 111 (91.0) | 108 (88.5) | 47 (38.5) | 66 (54.1) | 20 (16.4) | 13 (10.7) | 1 (0.8) |
| ≥ 4 (63) | 62 (98.4) | 60 (95.2) | 50 (79.4) | 48 (76.2) | 32 (50.8) | 22 (34.9) | 1 (1.6) |
| Non-diabetics | |||||||
| 1 (1184) | 448 (37.8) | 160 (13.5) | 288 (24.3) | 81 (6.8) | 95 (8.0) | 112 (9.5) | 0 (0.0) |
| 2 (597) | 390 (65.3) | 291 (48.7) | 212 (35.5) | 112 (18.8) | 106 (17.8) | 81 (13.6) | 2 (0.3) |
| 3 (312) | 269 (86.2) | 233 (74.7) | 139 (44.6) | 175 (56.1) | 62 (19.9) | 53 (17.0) | 5 (1.6) |
| ≥ 4 (111) | 108 (97.3) | 96 (86.5) | 83 (74.8) | 79 (71.2) | 52 (46.8) | 39 (35.1) | 1 (0.9) |
GI Gastrointestinal